Organon OGN
NYSE OGN
$13.75 +0.01 (+0.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Organon (OGN) Other Accumulated Expenses (2023)

Organon (OGN) posted quarterly Other Accumulated Expenses of $1.0 million for Q4 2023.

Organon (OGN) Other Accumulated Expenses (2023) Analysis & Trends

Organon has reported Other Accumulated Expenses for 1 years, with the latest figure at $1.0 million in Q4 2023.

  • Other Accumulated Expenses for Q4 2023 came in at $1.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $1.0 million (changed N/A YoY), and the FY2023 annual result was $1.0 million, changed N/A from the prior year.
  • Other Accumulated Expenses steadied at $1.0 million in Q4 2023.
  • Over five years, Other Accumulated Expenses peaked at $1.0 million in Q4 2023 and troughed at $1.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Organon 3.61 Bn 2.48 Bn 847.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 1.00 Mn